Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.6.3.1 (
NADPH oxidase
)
11,281
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
APP,
amyloid beta precursor protein
, is linked to the onset of Alzheimer's disease (AD). We have here found that transforming growth factor beta2 (TGFbeta2), but not TGFbeta1, binds to APP. The binding affinity of TGFbeta2 to APP is lower than the binding affinity of TGFbeta2 to the TGFbeta receptor. On binding to APP, TGFbeta2 activates an APP-mediated death pathway via heterotrimeric G protein G(o), c-Jun N-terminal kinase,
NADPH oxidase
, and caspase 3 and/or related caspases. Overall degrees of TGFbeta2-induced death are larger in cells expressing a familial AD-related mutant APP than in those expressing wild-type APP. Consequently, superphysiological concentrations of TGFbeta2 induce neuronal death in primary cortical neurons, whose one allele of the APP gene is knocked in with the V642I mutation. Combined with the finding indicated by several earlier reports that both neural and glial expression of TGFbeta2 was upregulated in AD brains, it is speculated that TGFbeta2 may contribute to the development of AD-related neuronal cell death.
...
PMID:Transforming growth factor beta2 is a neuronal death-inducing ligand for amyloid-beta precursor protein. 1622 82
Our earlier studies indicated that TGFbeta2-induced neuronal cell death by binding to the extracellular domain of
amyloid beta precursor protein
(
APP
) on the cell surface and by triggering an intracellular death signal pathway, mediated by a heterotrimeric G protein Go, Rac1/cdc42, ASK1, JNK,
NADPH oxidase
, and caspases in this order. Recently, transient axonal glycoprotein-1 (TAG-1), a glycophosphatidylinositol-linked protein, was identified as another natural ligand of
APP
. TAG-1 increases
APP
intracellular domain release and triggers FE65-dependent transcriptional activity in a gamma-secretase-dependent manner by binding to
APP
. In this study, we show that TAG-1 inhibits TGFbeta2-mediated neuronal cell death via
APP
by attenuating the binding of TGFbeta2 to
APP
in a gamma-secretase-independent manner. TAG-1 is expressed in murine hippocampal neurons at 8 weeks of age, but its expression is reduced at 8 and 20 months. These findings suggest that an age-related reduction of TAG-1 expression may predispose neurons to cell death, induced by the binding of TGFbeta2 to
APP
. This mechanism may contribute to the onset and the progression of Alzheimer's disease-relevant neuronal cell death.
...
PMID:TAG-1 is an inhibitor of TGFbeta2-induced neuronal death via amyloid beta precursor protein. 2018 61